Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraAntineoplastic Combined Chemotherapy ProtocolsGraft SurvivalTissue DonorsBusulfanCyclophosphamideBone Marrow PurgingHistocompatibility TestingCombined Modality TherapyHematopoietic Stem CellsHistocompatibilityTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationTreatment OutcomeRecurrenceHematopoiesisMice, Inbred C57BLLeukemia, Myeloid, AcuteRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsBone Marrow ExaminationPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic NeoplasmsImmunosuppressive AgentsRemission InductionSurvival AnalysisGraft RejectionHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsLeukemia, MyeloidLymphoma, Non-HodgkinTransplantation ImmunologyGraft vs Host ReactionStem Cell TransplantationImmunosuppressionLymphocyte DepletionAcute DiseaseLeukocyte TransfusionHeart TransplantationSurvival RateRetrospective StudiesColony-Forming Units AssayT-LymphocytesSevere Combined ImmunodeficiencyDisease-Free SurvivalMyelodysplastic SyndromesChimeraHLA AntigensFollow-Up StudiesActuarial AnalysisHematologic DiseasesEtoposideLung TransplantationCyclosporineCarmustinePrognosisBone DensityAntineoplastic AgentsCytarabineLymphocyte TransfusionCell DifferentiationNuclear FamilyFlow CytometryMice, Inbred BALB CGranulocyte Colony-Stimulating FactorOrgan TransplantationPancytopeniaMelphalanLeukocyte CountGraft vs Tumor EffectGraft vs Leukemia EffectLymphomaCytomegalovirus InfectionsSpleenBone ResorptionBone NeoplasmsMultiple MyelomaHodgkin DiseaseBreast NeoplasmsCells, CulturedFatal OutcomeMethotrexateNeoplasmsAntibodies, Monoclonal